OVARIAN NEOPLASMS

This phase 2 trial tested a combination of two drugs—paclitaxel (given intravenously and directly into the abdomen) and oral nilotinib—in 21 adults with cancers that had spread to the lining of the abdomen and could not be surgically removed. The goal was to see if the treatment …

This early-phase study tested whether adding indomethacin, a common anti-inflammatory drug, to standard platinum-based chemotherapy is safe for people with colorectal, esophageal, or ovarian cancers. The 13 participants received escalating doses of indomethacin alongside their ch…

This study tested a light-based technique called Raman spectroscopy to find ovarian cancer in blood and tissue samples. Researchers looked at samples from 160 women with symptoms or undergoing treatment. The goal was to see if this method can help detect cancer earlier and tell t…

This study looked at whether adding a special MRI measurement (called ADC) to the standard scoring system helps doctors more accurately tell if ovarian growths are cancerous. Researchers reviewed MRI scans from 66 women with suspicious ovarian lesions found on ultrasound. The goa…

This study looked at how behavioral factors, hormones, and natural body chemicals might influence tumor growth in ovarian cancer. Researchers studied 613 women with ovarian cancer to understand these connections. The goal was to gather knowledge, not to test a treatment.